Added: Yesica Yanez - Date: 24.03.2022 07:20 - Views: 10601 - Clicks: 2602
It has been reported that hyperprolactinemia may be associated with increased temporal lobe activity. Coexisting hyperprolactinemia Long-lasting 27 months normoprolactinemia Posttreatment CT scans showed progressive shrinkage of the pituitary tumor 2 mm associated with an empty-sella. It is proposed that, whenever TLE and hyperprolactinemia coexist, therapy with a DA agonist such as pergolide mesylate, resulting in normoprolactinemia, may be beneficial in TLE control.
Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. Search: Search. Advanced Quebec tle. Display options Display options. Create file Cancel. citation Subject: 1 selected item: - PubMed. Format: Summary Summary text Abstract Abstract text. MeSH and other data. Send Cancel.
Add to Collections Create a new collection Add to an existing collection. Name your collection: Name must be less than characters.International - Objectif Québec
Choose a collection: Unable to load your collection due to an error Please try again. Add Cancel. Add to My Bibliography My Bibliography. Unable to load your delegates due to an error Please try again. Your saved search Name of saved search:. Search terms:. Test search terms.
Would you like updates of new search ? : change. Frequency: Monthly Weekly Daily. Which day? Send at most: 1 item 5 items 10 items 20 items 50 items items items. Send even when there aren't any new. Optional text in :.
Save Cancel. Create a file for external citation management software Create Quebec tle Cancel. of items displayed: 5 10 15 20 50 Create RSS Cancel. RSS Link Copy. Full text links Cite Display options Display options. Abstract It has been reported that hyperprolactinemia may be associated with increased temporal lobe activity. Similar articles Control of hyperprolactinemia with pergolide. Mattox JH, et al. Int J Fertil. PMID: Kuba R, et al.
Epilepsy Res. Epub Aug 6. A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia. Lamberts SW, et al. J Clin Endocrinol Metab. Drug treatment of hyperprolactinemia. Chanson P, et al.
Ann Endocrinol Paris. Epub May PMID: Review. Association between Hyperprolactinemia and Granulomatous Mastitis. Nikolaev A, et al. Breast J. Epub Dec See all similar articles. Cited by 2 articles The role of dopamine aling in epileptogenesis. Bozzi Y, Borrelli E. Bozzi Y, et al. Front Cell Neurosci. Neuroprotective role of dopamine against hippocampal cell death. J Neurosci. References Lancet. Publication types Case Reports Actions. MeSH terms Adult Actions.
Female Actions. Humans Actions. Time Factors Actions. Substances Pergolide Actions. Prolactin Actions. Full text links [x] Springer. Copy Download.Quebec tle
email: [email protected] - phone:(866) 369-2115 x 3374
Hyperprolactinemia and temporal lobe epilepsy in a woman: concomitant and persistent prolactin suppression and temporal lobe epilepsy relief